BALZIVA-21 (ETHINYL ESTRADIOL; NORETHINDRONE) — FDA Approval ANDA076198 (BARR)
BALZIVA-21 (ETHINYL ESTRADIOL; NORETHINDRONE) — FDA Approval ANDA076198 (BARR) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: BALZIVA-21; Active ingredients: ETHINYL ESTRADIOL; NORETHINDRONE; Application number: ANDA076198.
| Brand name | BALZIVA-21 |
|---|---|
| Active ingredients | ETHINYL ESTRADIOL; NORETHINDRONE |
| Application number | ANDA076198 |
| Sponsor | BARR |
| Dosage form | TABLET |
| Route | ORAL-21 |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 20040422 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →